XML 33 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities    
Net income $ 12 $ 111
Add (deduct) adjustments to reconcile net income to net cash flows from operating activities    
Depreciation, amortization and accretion 456 456
Bad debts expense 53 54
Stock-based compensation expense 14 23
Deferred income taxes, net 22 52
Equity in earnings of unconsolidated entities (82) (83)
Distributions from unconsolidated entities 78 80
Loss on impairment of licenses 0 3
(Gain) loss on asset disposals, net 16 9
Other operating activities 4 3
Changes in assets and liabilities from operations    
Accounts receivable 19 (25)
Equipment installment plans receivable 7 (25)
Inventory 52 (35)
Accounts payable (124) (6)
Customer deposits and deferred revenues (9) 7
Accrued taxes 56 131
Accrued interest (1) 1
Other assets and liabilities (59) (22)
Net cash provided by operating activities 514 734
Cash flows from investing activities    
Cash paid for additions to property, plant and equipment (629) (526)
Cash paid for intangible assets (8) (585)
Advance payments for license acquisitions 0 (1)
Other investing activities 8 (10)
Net cash used in investing activities (629) (1,122)
Cash flows from financing activities    
Issuance of long-term debt 391 776
Repayment of long-term debt (209) (228)
Issuance of short-term debt 0 60
Repayment of short-term debt (60) 0
TDS Common Shares reissued for benefit plans, net of tax payments (3) (4)
UScellular Common Shares reissued for benefit plans, net of tax payments (6) (5)
Repurchase of TDS Common Shares (6) (20)
Repurchase of UScellular Common Shares 0 (18)
Dividends paid to TDS shareholders (76) (76)
Distributions to noncontrolling interests (2) (2)
Cash paid for software license agreements (20) (3)
Other financing activities 0 (1)
Net cash provided by financing activities 9 479
Net increase (decrease) in cash, cash equivalents and restricted cash (106) 91
Cash, cash equivalents and restricted cash    
Beginning of period 399 414
End of period $ 293 $ 505